Suspected black cohosh hepatotoxicity-Challenges and pitfalls of causality assessment

Maturitas

Volumn 63, Issue 4, 2009, Pages 302-314

  Teschke, Rolf ^a   Bahre, Ruediger ^a   Genthner, Alexander ^a   Fuchs, Johannes ^a   Schmidt Taenzer, Wolfgang ^a   Wolff, Albrecht ^a  

^a Klinikum Hanau   (Germany)

Author keywords

Actaea racemosa; Black cohosh; Causality assessment; Cimicifuga racemosa; Hepatotoxicity

Indexed keywords

ACETYLSALICYLIC ACID; AMINOSALICYLIC ACID; CIMICIFUGA RACEMOSA EXTRACT; DEXTROPROPOXYPHENE; FLUOXETINE; FOSINOPRIL; HERBACEOUS AGENT; IBUPROFEN; INSULIN; LABETALOL; LANSOPRAZOLE; LEVOTHYROXINE; METFORMIN; MULTIVITAMIN; PARACETAMOL; PSEUDOEPHEDRINE; VALACICLOVIR; VERAPAMIL;

CAUSAL ATTRIBUTION; CHOLELITHIASIS; CIMICIFUGA RACEMOSA; DIET SUPPLEMENTATION; DRUG WITHDRAWAL; FATTY LIVER; HERBAL MEDICINE; HUMAN; LIVER DISEASE; LIVER TOXICITY; MENOPAUSAL SYNDROME; REVIEW;

CIMICIFUGA; DIETARY SUPPLEMENTS; FEMALE; HEPATITIS, TOXIC; HUMANS; PLANT EXTRACTS;

CIMICIFUGA DAHURICA; CIMICIFUGA RACEMOSA;

EID: 68249138704     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.05.006     Document Type: Review

References (51)

1. Björnsson E., and Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 42 (2005) 481-489
2. Navarro V.J., and Senior J.R. Drug-related hepatotoxicity. N Engl J Med 354 (2006) 731-739
3. Teschke R., Gaus W., and Loew D. Kava extracts: safety and risks including rare hepatotoxicity. Phytomedicine 10 (2003) 440-446
4. Teschke R., Schwarzenboeck A., and Hennermann K.H. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol 20 (2008) 1182-1193
5. Teschke R., Schwarzenboeck A., and Hennermann K.H. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol 66 (2008) 758-766
6. Björnsson E. Drug-induced liver injury: Hy's rule revisited. Clin Pharmacol Ther 79 (2006) 521-528
7. Estes J.D., Stolpman D., Olyaei A., et al. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 138 (2003) 852-858
8. Mason A., and Sallie R. What causes fulminant hepatic failure of unknown etiology?. Am J Clin Pathol 104 (1995) 491-494
9. Shakil A.O., Kramer D., Mazariegos G.V., Fung J.J., and Rakela J. Akute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 6 (2000) 163-169
10. Gill R., and Sterling R. Acute liver failure. J Clin Gastroenterol 33 (2001) 191-198
11. Whiting P.W., Clouston A., and Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 177 (2002) 432-435
12. Lontos S., Jones R.M., Angus P.W., and Gow P.J. Acute liver failure associated with the use of herbal preparations containing black cohosh. Med J Aust 179 (2003) 390-391
13. Cohen S.M., O'Connor A.M., Hart J., Merel N., and Te H.S. Autoimmune hepatitis associated with the use of black cohosh. Menopause 11 (2004) 575-577
14. Levitsky J., Alli T.A., Wisecarver J., and Sorrell M.F. Fulminant liver failure associated with the use of black cohosh. Dig Dis Sci 50 (2005) 538-539
15. Lynch C.R., Folkers M.E., and Hutson W.R. Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver Transpl 12 (2006) 989-992
16. Nisbet B.C., and O'Connor R.E. Black cohosh-induced hepatitis. Del Med J 79 (2007) 441-444
17. Dunbar K., and Solga S.F. Black cohosh, safety, and public awareness. Liver Int 27 (2007) 1017-1018
18. Joy D., Joy J., and Duane P. Black cohosh: a cause of abnormal postmenopausal liver function tests. Climacteric 11 (2008) 84-88
19. Chow E.C.Y., Teo M., Ring J.A., and Chen J.W. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust 188 (2008) 420-422
20. EMEA: Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizoma (black cohosh, root). Available at: http://www.emea.europa.eu/pdfs/human/hmpc/26925806en.pdf. Accessed July 18, 2006.
21. EMEA: Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizoma (black cohosh, root). Available at: http://www.emea.europa.eu/pdfs/human/hmpc/26925806.pdf. Accessed November 15, 2008.
22. Mahady G.B., Low Dog T., Barrett M.L., et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 15 (2008) 628-638
23. Kerlin P. Herbal hepatitis-black cohosh. Workshop on the safety of black cohosh in clinical studies. Proceedings of the NIH, November 22 (2004) 24-26
24. Thomsen M., Vitetta L., Sali A., and Schmidt M. Acute liver failure associated with the use of herbal preparations containing black cohosh. Med J Aust 180 (2004) 598-599 [Letter to the Editor]
25. Cumming F.J., and Kelly L. Response to Letter to the Editor. Med J Aust 180 (2004) 599-600
26. O'Connor A.M., Merel N., Te H.S., and Cohen S.M. A case of autoimmune hepatitis associated with the use of black cohosh. Am J Gastroenterol 98 Suppl (2003) 5165
27. Cohen S.M. Hepatitis associated with black cohosh. Case 1. Workshop on the safety of black cohosh in clinical studies. Proceedings of the NIH, November 22 (2004) 22-24
28. Strom, LE; 2006. Nebraska judgement of September 8, 2006. Available at: www.ahpa.org/Portals/0/pdfs/06_0908_BlackCohosh_NebraskaDistrictCt.pdf.
29. Strom, LE. American Herbal Products Association 2006. Available at: http://ahpa.org/portals/0/pdfs/06_0908_Blackcohosh_NebraskaDistrictCt.pd f. Accessed February 11, 2009.
30. Levitsky J., Alli T.A., Wisecarver J., and Sorrell M.F. Fulminant liver failure associated with the use of black cohosh. Dig Dis Sci 53 (2008) 869
31. Cohen S.M. Hepatitis associated with black cohosh. Case 2. Workshop on the safety of black cohosh in clinical studies. Proceedings of the NIH, November 22 (2004) 23-24
32. Teschke R. Questions regarding causality in presumed black cohosh hepatotoxicity. Del Med J 80 (2008) 233-235
33. Nisbet B., and O'Connor R. Response to questions regarding causality in presumed black cohosh hepatotoxicity. Del Med J 80 (2008) 235
34. Naser B., and Liske E. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust 190 (2009) 99 [Letter to the Editor]
35. Teschke R. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust 190 (2009) 99-100 [Letter to the Editor]
36. Chow E.C.Y., Teo M., Ring J.A., and Chen J.W. Response to Letters to the Editor. Med J Aust 190 (2009) 100
37. Teschke R. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 16 (2009) 214 [Letter to the Editor]
38. Mahady G., Low Dog T., and Sarma D.N. Letter to the Editor (Reply). Menopause 16 (2009) 214-215
39. Teschke R., and Schwarzenboeck A. Suspected hepatotoxicity by Cimicifugae racemosae rhizoma (black cohosh, root): critical analysis and structured causality assessment. Phytomedicine 16 (2009) 72-84
40. Teschke R, Bahre R, Fuchs J, Wolff A. Black cohosh hepatotoxicity: quantitative causality evaluation in suspected 9 cases. Menopause; in press: 16.
41. Naser B., and Liske E. Adverse liver reactions to black cohosh: are they accurately reported?. Climacteric 11 Suppl 2 (2008) 114
42. Bénichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 11 (1990) 272-276
43. Danan G., and Bénichou C. Causality assessment of adverse reactions to drugs. I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46 (1993) 1323-1330
44. Bénichou C., Danan G., and Flahault A. Causality assessment of adverse reactions to drugs. II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 46 (1993) 1331-1336
45. Rochon J., Protiva P., Seeff L.B., et al. Reliability of the Roussel Uclaf causality assessment method for assessing causality in drug-induced liver injury. Hepatology 48 (2008) 1175-1183
46. Chalasani N., Fontana R.J., Bonkovsky H.L., et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 135 (2008) 1924-1934
47. Teschke R, Schmidt-Taenzer W, Wolff A. Hepatotoxicity by black cohosh assumed in 22 spontaneous reports; a thorough analysis; in press.
48. Low Dog T., Powell K.L., and Weisman S.M. Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief. Menopause 10 (2003) 299-313
49. Briese V., Stammwitz U., Friede M., and Henneicke von Zepelin H.H. Black cohosh with or without St. Johns's wort for symptom-specific climacteric treatment-results of a large-scale, controlled, observational study. Maturitas 57 (2007) 405-414
50. Sunyecz J.A. Letter to the Editor. Menopause 16 (2009) 216
51. Teschke R., Schwarzenboeck A., and Akinci A. Kava hepatotoxicity: a European view. N Zeal Med J 121 (2008) 1283. http://www.nzma.org.nz/journal/121-1283 ISSN: 1175 8716. Available at: http://www.nzma.org.nz/journal/121-1283